Bio-Rad Laboratories

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$693,200
$653,000
$651,600
$585,400
Gross Profit
345,200
343,400
345,300
306,000
EBITDA
114,300
120,600
477,200
133,500
EBIT
61,900
66,400
426,600
95,400
Net Income
720,000
-341,900
317,800
64,000
Net Change In Cash
693,200
653,000
651,600
585,400
Free Cash Flow
119,100
89,200
70,800
95,500
Cash
531,799
397,800
369,300
521,400
Basic Shares
27,012
26,923
27,228
27,955

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$2,583,200
$2,566,500
$2,671,262
$2,802,249
Gross Profit
1,343,600
1,378,900
1,426,946
1,567,330
EBITDA
475,900
-2,142,000
-654,800
-4,488,959
EBIT
270,500
-2,293,600
-800,700
-4,666,159
Net Income
759,900
-1,844,200
-637,324
-3,627,535
Net Change In Cash
2,583,200
2,566,500
2,671,262
2,802,249
Cost of Revenue
-39,570
Free Cash Flow
374,600
266,200
218,263
80,290
Cash
531,799
488,100
403,800
434,215
Basic Shares
27,281
28,214
29,209
29,785

Earnings Calls

QuarterEPS
2026-03-31
$0
2025-12-31
$2.51
2025-09-30
$2.26
2025-06-30
$2.61